Anti-inflammatory drugs selectively target sporangium development in Mucor
It is known that acetylsalicylic acid, an anti-inflammatory and anti-mitochondrial drug, targets structure development and functions of yeasts depending on elevated levels of mitochondrial activity. Using antibody probes, we previously reported that sporangia of Mucor circinelloides also contain inc...
Saved in:
Published in: | Canadian journal of microbiology Vol. 55; no. 12; p. 1392 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Canada
01-12-2009
|
Subjects: | |
Online Access: | Get more information |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | It is known that acetylsalicylic acid, an anti-inflammatory and anti-mitochondrial drug, targets structure development and functions of yeasts depending on elevated levels of mitochondrial activity. Using antibody probes, we previously reported that sporangia of Mucor circinelloides also contain increased mitochondrial activity, yielding high levels of 3-hydroxyoxylipins. This was, however, not found in Mortierella alpina (subgenus Mortierella). In this study we report that acetylsalicylic acid (aspirin) also targets sporangium development of Mucor circinelloides selectively, while hyphae with lower levels of mitochondrial activity are more resistant. Similar results were obtained when the anti-inflammatory compounds benzoic acid, ibuprofen, indomethacin, and salicylic acid were tested. The anti-inflammatory drugs exerted similar effects on this dimorphic fungus as found under oxygen-limited conditions. Interestingly, sporangium development of Mortierella alpina was found not to be selectively targeted by these drugs. Mortierella alpina, which could not exhibit dimorphic growth under oxygen-limited conditions, was also more sensitive to the anti-inflammatory drugs when compared with Mucor circinelloides. These results prompt further research to assess the applicability of these antimitochondrial antifungals to protect plants and animals against Mucor infections. |
---|---|
AbstractList | It is known that acetylsalicylic acid, an anti-inflammatory and anti-mitochondrial drug, targets structure development and functions of yeasts depending on elevated levels of mitochondrial activity. Using antibody probes, we previously reported that sporangia of Mucor circinelloides also contain increased mitochondrial activity, yielding high levels of 3-hydroxyoxylipins. This was, however, not found in Mortierella alpina (subgenus Mortierella). In this study we report that acetylsalicylic acid (aspirin) also targets sporangium development of Mucor circinelloides selectively, while hyphae with lower levels of mitochondrial activity are more resistant. Similar results were obtained when the anti-inflammatory compounds benzoic acid, ibuprofen, indomethacin, and salicylic acid were tested. The anti-inflammatory drugs exerted similar effects on this dimorphic fungus as found under oxygen-limited conditions. Interestingly, sporangium development of Mortierella alpina was found not to be selectively targeted by these drugs. Mortierella alpina, which could not exhibit dimorphic growth under oxygen-limited conditions, was also more sensitive to the anti-inflammatory drugs when compared with Mucor circinelloides. These results prompt further research to assess the applicability of these antimitochondrial antifungals to protect plants and animals against Mucor infections. |
Author | Kriel, Wilmarie M Swart, Chantel W Kock, Johan L F Pohl, Carolina H Leeuw, Ntsoaki J van Wyk, Pieter W J Ncango, Desmond M |
Author_xml | – sequence: 1 givenname: Ntsoaki J surname: Leeuw fullname: Leeuw, Ntsoaki J organization: Department of Microbial, Biochemical and Food Biotechnology, University of the Free State, P.O. Box 339, Bloemfontein 9301, South Africa – sequence: 2 givenname: Chantel W surname: Swart fullname: Swart, Chantel W – sequence: 3 givenname: Desmond M surname: Ncango fullname: Ncango, Desmond M – sequence: 4 givenname: Wilmarie M surname: Kriel fullname: Kriel, Wilmarie M – sequence: 5 givenname: Carolina H surname: Pohl fullname: Pohl, Carolina H – sequence: 6 givenname: Pieter W J surname: van Wyk fullname: van Wyk, Pieter W J – sequence: 7 givenname: Johan L F surname: Kock fullname: Kock, Johan L F |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/20029531$$D View this record in MEDLINE/PubMed |
BookMark | eNo1j81KxDAURoMozo_iG0heIHpzk8ZmOQz-MuJGcTnctrel0qYlTYV5ewfUzXcWBw58K3EahsBCXGm40dr420_wCrw7EUttc1AG77KFWE3TF4AGY925WCAA-szopXjZhNSqNtQd9T2lIR5kFedmkhN3XKb2m7uDTBQbTnIah0ihaedeVnwUw9hzSLIN8nUuh3ghzmrqJr7841p8PNy_b5_U7u3xebvZqdIZSCpz1hDmumZTYF4fRxfWokZbOk2eSTN6n-W-QFM7qhiIyqwCYjAVo8O1uP7tjnPRc7UfY9tTPOz_T-EPR_5NwA |
CitedBy_id | crossref_primary_10_3390_vaccines10081266 crossref_primary_10_3389_fpls_2015_00859 crossref_primary_10_1517_17460441_2011_575358 crossref_primary_10_1021_cr100061j crossref_primary_10_3390_antibiotics9110812 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1139/W09-096 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1480-3275 |
ExternalDocumentID | 20029531 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -~X .55 00T 0R~ 29B 2QL 2XV 36B 3O- 3V. 4.4 4IJ 53G 5GY 5RE 5RP 6J9 7RV 7X2 7X7 88A 88E 88I 8AF 8AO 8CJ 8FE 8FH 8FI 8FJ 8FQ 8G5 A8Z AAHBH AAIKC AAMNW ABCQX ABDBF ABEFU ABJNI ABTAH ABUWG ACGFO ACGFS ACGOD ACNCT ACPRK ADBBV AEGXH AENEX AFFNX AFKRA AFRAH AHMBA AIAGR ALIPV ALMA_UNASSIGNED_HOLDINGS APEBS ATCPS AZQEC BBNVY BCR BENPR BHPHI BKEYQ BKSAR BLC BPHCQ BVXVI CAG CCPQU CGR COF CS3 CUY CVF D1J D8U DU5 DWQXO EAD EAP EAS EBC EBD EBS ECC ECM EDH EIF EJD EMB EMK EMOBN EPL EST ESTFP ESX EX3 F5P FYUFA GNUQQ GUQSH HCIFZ HMCUK HZ~ H~9 IAG IAO ICQ IEA IEP IHR INH INR IPNFZ ISN ISR ITC L7B LK8 M0K M0L M1P M2O M2P M2Q M3C M3G M7P ML0 MM. MV1 MVM NAPCQ NEJ NMEPN NPM NRXXU NYCZX O9- OHT ONR OVD P2P PCBAR PQQKQ PRG PROAC PSQYO PV9 QF4 QM4 QN7 QO4 QRP RIG RRCRK RRP RZL S10 SV3 TEORI TN5 TUS U5U UKHRP VQG WH7 WOW X7M YZZ ZCG ZGI ZY4 |
ID | FETCH-LOGICAL-c630t-5643a281fe3b28f3b21b442124c61a9ea1e299589b23f6ade0aac5d0ae03de262 |
IngestDate | Sun Jun 23 00:30:17 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c630t-5643a281fe3b28f3b21b442124c61a9ea1e299589b23f6ade0aac5d0ae03de262 |
PMID | 20029531 |
ParticipantIDs | pubmed_primary_20029531 |
PublicationCentury | 2000 |
PublicationDate | 2009-12-01 |
PublicationDateYYYYMMDD | 2009-12-01 |
PublicationDate_xml | – month: 12 year: 2009 text: 2009-12-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Canada |
PublicationPlace_xml | – name: Canada |
PublicationTitle | Canadian journal of microbiology |
PublicationTitleAlternate | Can J Microbiol |
PublicationYear | 2009 |
SSID | ssj0010346 |
Score | 1.9649532 |
Snippet | It is known that acetylsalicylic acid, an anti-inflammatory and anti-mitochondrial drug, targets structure development and functions of yeasts depending on... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 1392 |
SubjectTerms | Animals Anti-Inflammatory Agents, Non-Steroidal - pharmacology Antifungal Agents - pharmacology Aspirin - pharmacology Benzoic Acid - pharmacology Ibuprofen - pharmacology Indomethacin - pharmacology Mitochondria - drug effects Mortierella - drug effects Mortierella - growth & development Mucor - drug effects Mucor - growth & development Mucormycosis - prevention & control Plant Diseases - microbiology Plant Diseases - prevention & control Salicylic Acid - pharmacology |
Title | Anti-inflammatory drugs selectively target sporangium development in Mucor |
URI | https://www.ncbi.nlm.nih.gov/pubmed/20029531 |
Volume | 55 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NS8MwFA-bIngRv78lB2-j2KZt1hxFJyJsFxW9Sdqko2C7sa6I_70vSbuG-YEevISS0FDy--X1veR9IHROotRNQhE7kWR9J6Be6jChPABS6fuJ71PpqUDh2_v-6Dm6HgSDTqepmtH2_SvS0AdYq8jZP6C9mBQ64BkwhxZQh_ZXuF8W88yBiQDp3Nygi1k1LnulLngDsu0V9E3t_t1TFi0vxlmVN7FT2jMgK3rDKpnMbL11kcTAyjSRZ20SJ8uvp9KXRaN5OQHl1Lp1euMmOkjFM8zla29xuDMCdMcTI_zKXMXTLE6DQAQZLwIQXrmy6uuh5piCWS4f0ojWIAKJT0ydlEb2mhS9DceIJUlBMyVfi3hfZUh9Unc6phauBeo016gqxxMWmr_Lz6NLubaboS7qguaklOur4WpbDyOgJuxafcNF_QUqm3T91pJlojWUh020UZsW-NJwYgt1ZLGN1kyx0fcddPeJGVgzA1vMwIYZuGUGtpiBswJrZuyix5vBw9WtU1fScBLqu3MnBL2Tk8iDDRjD7oTGiwPlCxAk1ONMck-CWhJGLCZ-SrmQLuewg10uXV9IQskeWikmhTxAmPfB5hZUMtH3AsECTkUUMRHGjBOecvcQ7ZtFeJmadCkvzfIcfTtyjNZbypyg1RT2ojxF3VJUZxqDD0ieWCk |
link.rule.ids | 782 |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Anti-inflammatory+drugs+selectively+target+sporangium+development+in+Mucor&rft.jtitle=Canadian+journal+of+microbiology&rft.au=Leeuw%2C+Ntsoaki+J&rft.au=Swart%2C+Chantel+W&rft.au=Ncango%2C+Desmond+M&rft.au=Kriel%2C+Wilmarie+M&rft.date=2009-12-01&rft.eissn=1480-3275&rft.volume=55&rft.issue=12&rft.spage=1392&rft_id=info:doi/10.1139%2FW09-096&rft_id=info%3Apmid%2F20029531&rft_id=info%3Apmid%2F20029531&rft.externalDocID=20029531 |